Skip to main content

Three ways insurers can better assess the risk of weight loss jabs

Woman checking her weight on a scale at home, with a semaglutide injection pen nearby, indicating her commitment to managing obesity and achieving weight loss goals

Swiss Re has made three recommendations on how insurers can leverage the results of behavioural science experiments to better assess risk and support policyholders using weight loss jabs to reduce their waistlines.

In a paper titled Insurers, here’s how to unlock the GLP-1 benefits with behavioural science, Swiss Re pointed out how providers need to rethink their traditional approach to assessing an individual’s

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Q&A: Julian Roberts, WTW

As climate volatility disrupts long-established farming traditions, Julian Roberts, managing director of risk and analytics (alternative risk transfer solutions) at WTW, explains why parametric insurance could be the tool that helps farmers plus the wider agricultural supply chain build resilience.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here